Taipei Buddhist Tzu Chi Medical Foundation Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2020
NCT04639674
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Department of Pediatrics, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation,Taiwan | Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation | Taipei Buddhist Tzu Chi Medical Foundation

Active Ingredients

Drugs in Other Trials (1)

kremezin (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1